» Articles » PMID: 28344599

Does Ultrasound Measurement Improve the Accuracy of Electronic Brachytherapy in the Treatment of Superficial Non-melanomatous Skin Cancer?

Overview
Date 2017 Mar 28
PMID 28344599
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Electronic brachytherapy (eBT) is a form of contact radiation therapy used for thin superficial non-melanomatous skin cancers (NMSCs). An accurate measurement of diameter and depth is important for eBT treatment planning. Therefore, we compared clinical measurements by an experienced physician to measurements obtained using ultrasound (US), an objective imaging modality, in order to determine if clinical measurements were accurate enough for adequate NMSC treatment.

Material And Methods: Eighteen patients with 20 biopsy-proven NMSCs first had a clinical examination and then an US evaluation prior to starting eBT. One physician provided a clinical measurement for diameter and depth based on physical examination during radiation oncology consultation. The patients then had an US evaluation with a 14 or 18 MHz US unit, to determine both the diameter and depth measurements; eBT dose prescription was done using the US derived measurements. The clinical measurements and US measurements were compared using a -test.

Results: Seventeen lesions were basal cell carcinoma and 3 lesions were squamous cell carcinoma. The most common location was the nose (10 lesions). The difference between the clinical and the US derived measurements for the second largest diameter was found to be statistically significant ( = 0.03), while the difference for the largest diameter of the lesions was not ( = 0.24). More importantly, the depth measurements obtained with US were also found to be significantly different from the clinical estimates ( = 0.02). All patients have had a complete response to therapy with a median follow-up of 24 months.

Conclusions: Statistically different measurements were obtained in 2 of 3 parameters used in choosing applicator size and prescription depth using an US assessment. The data presented suggests that US is a more objective modality than clinical judgment for determining superficial NMSC diameter and prescription depth for personalized eBT planning.

Citing Articles

Preliminary Clinical Experience with a Novel Optical-Ultrasound Imaging Device on Various Skin Lesions.

Csany G, Gergely L, Kiss N, Szalai K, Lorincz K, Strobel L Diagnostics (Basel). 2022; 12(1).

PMID: 35054371 PMC: 8774695. DOI: 10.3390/diagnostics12010204.


Electronic brachytherapy for treatment of non-melanoma skin cancers: clinical results and toxicities.

Goyal U, Cheung M, Suszko J, Laughlin B, Kim Y, Askam J J Contemp Brachytherapy. 2021; 13(5):497-503.

PMID: 34759973 PMC: 8565634. DOI: 10.5114/jcb.2021.109753.


Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma.

Krivoshapkin A, Gaytan A, Abdullaev O, Salim N, Sergeev G, Marmazeev I Surg Neurol Int. 2021; 12:517.

PMID: 34754567 PMC: 8571379. DOI: 10.25259/SNI_494_2021.


The feasibility of using ultrasound during follow-up for superficial non-melanoma skin cancers after electronic brachytherapy.

Goyal U, Suszko J, Stea B J Contemp Brachytherapy. 2018; 9(6):535-539.

PMID: 29441097 PMC: 5807995. DOI: 10.5114/jcb.2017.72358.

References
1.
Wong S, Kaur A, Back M, Lee K, Baggarley S, Lu J . An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy. Radiat Oncol. 2011; 6:9. PMC: 3035589. DOI: 10.1186/1748-717X-6-9. View

2.
Paravati A, Hawkins P, Martin A, Mansy G, Rahn D, Advani S . Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer. Pract Radiat Oncol. 2015; 5(6):e659-64. DOI: 10.1016/j.prro.2015.07.002. View

3.
Kwan W, Wilson D, Moravan V . Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 2004; 60(2):406-11. DOI: 10.1016/j.ijrobp.2004.03.006. View

4.
Svoboda V, Kovarik J, Morris F . High dose-rate microselectron molds in the treatment of skin tumors. Int J Radiat Oncol Biol Phys. 1995; 31(4):967-72. DOI: 10.1016/0360-3016(94)00485-4. View

5.
Tormo A, Celada F, Rodriguez S, Botella R, Ballesta A, Kasper M . Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy. 2014; 6(2):167-72. PMC: 4105643. DOI: 10.5114/jcb.2014.43247. View